Company profilePharmaceutical#428 of 1,318 in Pakistan✓ No DRAP alerts

CREST PHARMACEUTICALS

Pharmaceutical company · 37 brands · 25 molecules

Ranked #67 of 100 companies in Gastro

37 registered products 32 pharmaceutical brands 25 distinct molecules 0 DRAP alerts

Company overview

37
registered products
32
pharmaceutical brands
25
distinct molecules
2
therapeutic classes
0
DRAP alerts

CREST PHARMACEUTICALS is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 37 product registrations across 25 distinct molecules. Its portfolio is concentrated in Gastro and Anti-Infectives. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by CREST

3 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Pain Management 1
Anti-Infectives 1

Top molecules by brand count

Lumefantrine5 brands
Artemether5 brands
Diclofenac4 brands
Lignocaine3 brands
Levofloxacin3 brands
Paroxetine2 brands
Azithromycin2 brands
Esomeprazole2 brands
Omeprazole1 brand

Therapeutic classes

Gastro · 1Anti-Infectives · 1

Conditions treated

Ulcer/Reflux/Flatulence/Acidity · 1General Infections · 1

Price band (DRAP official ceilings)

Registered products priced by source
Servaid2 products · Rs 290 – Rs 345
Median across source: Rs 317.5

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

BIO LABS (PVT) LTD. holds 138 molecules not in this portfolio
000 I.UAmlodipineAprepitantAremetherArtemetherArtesunate
NEUTRO PHARMA (PVT) LTD. holds 124 molecules not in this portfolio
AcetylcysteineAcyclovirAlbendazoleAmikacinAnastrazoleAnastrozole

Get the full profile for CREST

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.